FONT-SIZE Plus   Neg

Tudou To Collaborate With CCTV In Broadcasting Olympics-Focused "London Action"

China-based Internet video company Tudou Holdings Limited (TUDO) said Wednesday it has entered into a joint collaboration with China Central Television Sports & Entertainment Ltd., or CCTV, which is China's state television broadcaster and the exclusive broadcaster for the London 2012 Olympic Games in China.

Tudou said that as part of the collaboration the two companies will jointly broadcast London Action, a specially designed series of programs focusing on the Olympics.

According to the company, today marks the beginning of the 100-day countdown to the London 2012 Olympic Games and the launch of London Action, which will be made available exclusively to Tudou's 227 million monthly unique visitors through its Olympics channel.

London Action represents CCTV's first theme program focused on the Olympics that will merge a variety of media formats, including news, interviews, documentaries and other feature stories to provide viewers with a holistic perspective of the Olympics.

In addition to exclusive access to London Action, Tudou said it will enhance its users' experience by allowing them to interact, comment and share content with other users.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Visa Inc. (V) on Monday reported an increase in profit for the fourth quarter, as revenues jumped driven largely by increase in customer spending and inclusion of Europe business. Earnings and revenues trumped Wall Street expectations. Foster City, California-based Visa's fourth-quarter profit rose... As Sony Corp. prepares to launch the new PlayStation 4 Pro gaming console on November 10, several new games that are compatible with the console have also been confirmed for launch. Game developers are readying to provide PlayStation 4 Pro support for many games on PS4. Shares of Advaxis Inc. dropped more than 13 percent in pre-market activity before paring losses to just more than 5 percent after the company said that it was not able to complete the second stage of the Phase 2 GOG-0265 trial as designed due to a clinical hold that affected its clinical development programs last year.
comments powered by Disqus
Follow RTT